Sodium Channels Voltage-Gated Anticancer Agent Oxaliplatin on Neuronal A Possible Explanation for a Neurotoxic Effect of the

[1]  B. Hille,et al.  Ionic channels of excitable membranes , 2001 .

[2]  F. Grolleau,et al.  Dorsal unpaired median neurones in the insect central nervous system: towards a better understanding of the ionic mechanisms underlying spontaneous electrical activity. , 2000, The Journal of experimental biology.

[3]  M. Bekradda,et al.  Oxaliplatin: a new therapeutic option in colorectal cancer. , 1999, Seminars in oncology.

[4]  E. Raymond,et al.  Oxaliplatin: a review of preclinical and clinical studies. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  J. Robert,et al.  Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  F. Grolleau,et al.  Two distinct low-voltage-activated Ca2+ currents contribute to the pacemaker mechanism in cockroach dorsal unpaired median neurons. , 1996, Journal of neurophysiology.

[7]  C. C. Yang,et al.  Tetrodotoxin poisoning in Taiwan: an analysis of poison center data. , 1996, Veterinary and human toxicology.

[8]  D. Stewart,et al.  Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Malécot,et al.  Patch-clamp Study of the Properties of the Sodium Current in Cockroach Single Isolated Adult Aminergic Neurones , 1990 .

[10]  J. C. Houwelingen,et al.  Prevention of cisplatin neurotoxicity with an ACTH (4–9) analogue in patients with ovarian cancer , 1990 .

[11]  Roy E. Furman,et al.  Cisplatin neuropathy. Risk factors, prognosis, and protection by WR‐2721 , 1988, Cancer.

[12]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[13]  E. Gamelin,et al.  Long-term pharmacokinetic behavior of platinum after cisplatin administration , 2004, Cancer Chemotherapy and Pharmacology.

[14]  T. Hambley,et al.  Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin. , 1997, British Journal of Cancer.

[15]  M. Ychou,et al.  Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.